HS Diagnomics GmbH
Key figures / Profile
- founded in 2012
- T-cell receptor profiling by ultra-deep sequencing starting from tissue, blood samples or DNA (available for human and mouse samples)
- proprietary technology called TCRsafe: display the T-cell receptor repertoire in blood and tissue samples, up to the single cell level and up to every single nucleotide and translated peptide of the TCR.
- planning to optimize the method in future cooperations with the goal to establish novel individual cancer therapies based on T-cells.
In all scientific projects, clinical testings of drugs, diagnostic technologies, where there is a need to monitor the behavior of the adaptive immune system, our TCRsafe technology can be directly and easily implemented. The key components and applications are:
- Ultra-deep T cell receptor (TCR) profiles from blood, tissue, DNA samples
- Comparison of TCR profiles in time series or multi-sample studies to find common elements
- Systematic analysis of T cell response under various conditions
- Identification of tumor reactive TCRs